More than 400,000 patients around the world have treated their obstructive sleep apnea (OSA) with SomnoDent therapy. As a SomnoDent patient, we invite you to share your treatment journey so other patients may rediscover a good night’s rest.
Home > Share Your SomnoDent Story
To delight our customers and patients with the highest quality products and services for the treatment of Obstructive Sleep Apnea (OSA).
We will achieve that mission by relentlessly implementing the company’s core values on a daily basis: Integrity, Customer Focus, People/Patients, Teamwork, Quality, Respect, and Innovation.
SomnoMed is a publicly traded company on the Australian Stock Exchange (ASX:SOM). Please visit our Investor section.
© 2020 SomnoMed.com.
Dear Customers, Partners and Friends,
Thank you for your support over the last 3 months whilst we battled the COVID-19 virus together. Whilst globally the threat of COVID-19 is not over, our focus has now shifted to how we can best support your business and patients, in a post-COVID world.
While our service levels were impacted by federal and state imposed shutdowns, I’m pleased to advise that our global supply chain is functioning at 80% of pre-COVID levels, and will only continue to improve as airline freight capacity is fully restored.
During the last 3 months, we also took the opportunity to raise additional capital, with SomnoMed now in its best financial position it has ever been. You’ll see a number of new products, initiatives and technologies all designed to support you, our dental and medical partners, released under the banner “SomnoMed Re-imagined” very soon.
Thank you for your support over this difficult period and I look forward to introducing you to SomnoMed Re-imagined !
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.